Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Ovarian germ cell tumor
Stage/Subtype:  stage I ovarian germ cell tumor
Country:  U.S.A.
Trial Type:  Treatment
Results 1-6 of 6 for your search:
Start Over
Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients with Germ Cell Tumors
Status: Active
Phase: Phase III
Type: Treatment
Age: 0 to 49
Trial IDs: AGCT1531, NCI-2017-00178, NCT03067181
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 10 to 69
Trial IDs: MT2005-21, NCI-2010-01700, 2006LS032, UMN-2006LS032, UMN-MT2005-21, UMN-0608M90586, NCT00432094
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: S1609, NCI-2016-01041, NCT02834013
Weight-Based Dose Paclitaxel and Carboplatin in Treating Overweight Patients with Gynecologic Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 19 and over
Trial IDs: CASE13815, NCI-2016-01650, NCT02756013
Durvalumab and Tremelimumab in Treating Patients with Relapsed or Refractory Germ Cell Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 17-160, NCI-2017-01093, NCT03158064
Pembrolizumab in Treating Patients with Ovarian, Endometrial, Fallopian Tube, or Primary Peritoneal Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: Pro00068544, NCI-2016-01139, NCT02728830
Start Over